US Patent 10533178 Methods for modulating Ataxin 2 expression
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+345 characters)
Article
Patent abstract
Disclosed herein are methods for decreasing Ataxin 2 mRNA and protein expression. Such methods are useful to treat, prevent, or ameliorate Ataxin 2 associated diseases, disorders, and conditions. Such Ataxin 2 associated diseases include spinocerebellar ataxia type 2 (SCA2), amyotrophic lateral sclerosis (ALS), and parkinsonism.
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
C. Frank Bennett0
Daniel R. Scoles0
Gene Hung0
Stefan M. Pulst0
Susan M. Freier0
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
105331780
Date of Patent
January 14, 2020
0Patent Application Number
159730880
Date Filed
May 7, 2018
0Patent Primary Examiner
Edits on 31 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10533178 Methods for modulating Ataxin 2 expression
Infobox
Is a
Patent jurisdiction
Patent number
10533178
Date of patent
January 14, 2020
Patent application number
15973088
Date Filed
May 7, 2018
Patent primary examiner
Find more entities like US Patent 10533178 Methods for modulating Ataxin 2 expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.